Co-administration with CYP3A4 inhibitors

Lumeva · Episodic migraine

MI-2026-0778RoutineClosedWithin SLA

LOLuis OrtegaMSL, Neurology (Iberia)

Received: 30 Jul 2026, 11:36 UTC
Channel: Phone
Requestor type: HCP
Country / region / team: Italy · Europe · MI Europe
Category: Drug interaction
Response type: Standard response
Owner: LOLuis Ortega
Due: 04 Aug 2026, 11:36 UTC
Responded: 01 Aug 2026, 19:36 UTC
Quality review: Not required
Related insight: —
Related standard response: SR-LMV-007 · Co-administration with CYP3A4 inhibitors (v3)

Workflow

12-stage inquiry workflow (PRD §16). Advancing records an audit event.

Current stageClosedDemo action — not persisted

Routine: 120 h target · Routine 120 h / Urgent 48 h / Critical 24 h

SLA hours

120

Elapsed

56 h

to response

Remaining

64 h

47%

01 Aug 2026, 19:36 UTC
Response sent
Standard response · quality review not required
04 Aug 2026, 11:36 UTC
SLA due (120 h)
30 Jul 2026, 11:36 UTC
Received via Phone
HCP · Italy
30 Jul 2026, 11:36 UTC
Triage and assignment
Urgency Routine · assigned to MI Europe

Demo — drafts are not persisted

AI suggestion available for non-safety inquiries

Draft response

No audit events for this record

Create, update, approve and export events appear here with user, timestamp, previous and new values.

Data lineage: MI inquiry platform (IRMS, INT-05) · received 30 Jul 2026 · hourly sync.